BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16222612)

  • 1. Hormone replacement therapy in postmenopausal women with diabetes mellitus.
    Thijs A; Stehouwer CD
    Semin Vasc Med; 2002 May; 2(2):215-9. PubMed ID: 16222612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy with vitamin C and E supplementation on plasma thyroid hormone levels in postmenopausal women with Type 2 diabetes.
    Naziroğlu M; Simşek M
    Biomed Pharmacother; 2009 Dec; 63(10):717-22. PubMed ID: 19917523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hormone replacement therapy prescribed for postmenopausal diabetic women?
    Feher MD; Isaacs AJ
    Br J Clin Pract; 1996 Dec; 50(8):431-2. PubMed ID: 9039712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hormone replacement therapy on microvascular function in healthy and Type 2 diabetic postmenopausal women.
    Gooding KM; MacLeod KM; Spyer G; Ewings P; Tooke JE; Shore AC
    Diabet Med; 2005 May; 22(5):536-42. PubMed ID: 15842506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM.
    Sattar N; Jaap AJ; MacCuish AC
    Diabet Med; 1996 Sep; 13(9):782-8. PubMed ID: 8891452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use.
    Gower BA; Muñoz J; Desmond R; Hilario-Hailey T; Jiao X
    Obesity (Silver Spring); 2006 Jun; 14(6):1046-55. PubMed ID: 16861610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
    Masding MG; Stears AJ; Burdge GC; Wootton SA; Sandeman DD
    Diabet Med; 2006 Jul; 23(7):768-74. PubMed ID: 16842482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?].
    Ancelin ML; Berr C
    Psychol Neuropsychiatr Vieil; 2003 Dec; 1(4):251-7. PubMed ID: 15683960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hormone replacement therapy on the cardiovascular system].
    Payer J
    Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.